Most Read Articles
01 Nov 2019
Women with hypertensive disorders of pregnancy, especially pre-eclampsia, are at heightened risk of developing cardiovascular disorder and chronic hypertension, with the risk becoming apparent soon after pregnancy, a study has found.
Roshini Claire Anthony, 29 May 2019

Gestational diabetes and abnormal glucose levels in pregnancy, as determined with an oral glucose challenge test (OGCT) at 24–28 weeks gestation, could signal a future risk of cardiovascular disease (CVD)*, according to a recent study.

07 Jul 2019
Plasma creatinine kinase activity, measure during early pregnancy, influences blood pressure during pregnancy and contributes to severe gestational hypertension diagnosed before 34 weeks of gestation, according to a recent study. There is no association between creatinine kinase and other hypertensive disorders during pregnancy.
Pank Jit Sin, 16 Oct 2019
While a diagnosis of cancer is often met with concern and devastation, the same is barely true for heart failure. However, the mortality rate for those suffering from heart failure is worse than some common cancers, such as prostate and breast cancers. 

Reablation common after cavo tricuspid isthmus ablation

14 Jan 2020

Reablation for atrial flutter and ablation for atrial fibrillation (AF) remain relatively common after cavo tricuspid isthmus ablation (CTIA), a recent study has found.

The study included 2,409 patients (median age, 66 years; 81 percent male) undergoing their first CTIA procedure between 2010 and 2016. Incidences of repeat CTIA or ablation for AF were documented until 1 March 2018. Majority of the population (n=2,288; 95 percent) achieved acute procedural success; 13 participants (0.5 percent) experienced complications.

Over a mean follow-up duration of 4.0±1.7 years, 242 patients required repeat CTIA, yielding a rate of 10 percent. Slightly more patients required ablation for AF (13.5 percent; n=326). Thirty-eight (2 percent) underwent both procedures.

Cox regression analysis found that patients who had longer operation times for the first CTIA procedure (hazard ratio [HR], 1.003, 95 percent confidence interval [CI], 1.001–1.006; p=0.01) and having an unsuccessful initial operation (HR, 3.42, 95 percent CI, 2.10–5.55; p<0.0001) were significantly more likely to need repeat procedures. Older age was likewise significantly associated (75 vs <65 years: HR, 0.66, 95 percent CI, 0.44–0.97; p=0.04).

In comparison, the use of a contact force sensing catheter emerged as a significant risk factor for having to undergo ablation for AF (HR, 1.43, 95 percent CI, 1.13–1.81; p=0.003). Other pertinent factors were the presence of valvular heart disease (HR, 0.39, 95 percent CI, 0.21–0.72; p=0.002) and known AF prior to CTIA (HR, 1.71, 95 percent CI, 1.07–2.73; p=0.02).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Nov 2019
Women with hypertensive disorders of pregnancy, especially pre-eclampsia, are at heightened risk of developing cardiovascular disorder and chronic hypertension, with the risk becoming apparent soon after pregnancy, a study has found.
Roshini Claire Anthony, 29 May 2019

Gestational diabetes and abnormal glucose levels in pregnancy, as determined with an oral glucose challenge test (OGCT) at 24–28 weeks gestation, could signal a future risk of cardiovascular disease (CVD)*, according to a recent study.

07 Jul 2019
Plasma creatinine kinase activity, measure during early pregnancy, influences blood pressure during pregnancy and contributes to severe gestational hypertension diagnosed before 34 weeks of gestation, according to a recent study. There is no association between creatinine kinase and other hypertensive disorders during pregnancy.
Pank Jit Sin, 16 Oct 2019
While a diagnosis of cancer is often met with concern and devastation, the same is barely true for heart failure. However, the mortality rate for those suffering from heart failure is worse than some common cancers, such as prostate and breast cancers.